STOCK TITAN

Israel Acq A (ISRLF) DEF 14A Filings

ISRLF OTC

Here are the DEF 14A proxy statements from Israel Acq Corp A (ISRLF) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ISRLF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ISRLF filings page.

Rhea-AI Summary

Israel Acquisitions Corp is asking shareholders at a January 16, 2026 extraordinary meeting to approve changes that would extend the deadline to complete a business combination. The board proposes amending the company’s charter and trust agreement to allow up to 12 additional one‑month extensions beyond the current January 18, 2026 termination date, pushing the possible deadline to January 18, 2027. For each monthly extension, the sponsor or its affiliates may deposit into the trust account the lesser of $5,000 or $0.05 per public share, in exchange for a non‑interest‑bearing promissory note. Public shareholders can redeem their shares for cash in connection with the vote; as of the December 19, 2025 record date, the trust held about $9.9 million, or roughly $12.72 per public share, versus a $12.36 OTC market price. The company has a signed business combination agreement with Gadfin Ltd. but notes there is no assurance the deal will close, and its shares have been delisted from Nasdaq and now trade on the OTC Markets.